Searching content for nuvaring

Results 1 - 9 of 9 for nuvaring

Results Filter

By article type

Sort by

Format

  1. Practice

    Newer non-oral hormonal contraception

    Deborah Bateson, Kathleen McNamee, Paula Briggs
    (Published 14 February 2013)

    (NuvaRing) (fig 2 ⇓ ) Long acting reversible methods—the levonorgestrel intrauterine ... (Evra). Jacek Kutyba/Dreamstime.com Vaginal ring (NuvaRing ...

  2. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Julie M Chandler
    (Published 17 May 2012)

    thromboembolism (VTE) in users of NuvaRing® (etonogestrel/ethinylestradiol containing vaginal ring) compared with ... et al1. The risk of VTE associated with NuvaRing® use has been studied in a large, controlled, ... NuvaRing® (TASC) funded by Merck, (known as MSD outside the US and Canada). In this study, incidence rates ...

  3. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Øjvind Lidegaard
    (Published 25 May 2012)

    which I have previously refuted. But, again, the assumption that all users of the Patch and NuvaRing ... the data. Many users of patch and of NuvaRing® were switchers, and thus also long term users. And many ... of, in this case NuvaRing® and the Patch, then we should also find a low risk of thrombosis for COC ...

  4. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Anne Szarewski
    (Published 14 May 2012)

    of oestrogen-containing contraceptives. NuvaRing was launched in Denmark in late 2001 / early 2002, ... since the study period began in 2001, all users of NuvaRing and EVRA must be new users, and more likely ... susceptibles). The effect of duration of use is most clearly seen for NuvaRing in Table 4, where the relative ...

  5. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Øjvind Lidegaard
    (Published 24 May 2012)

    users of NuvaRing® have been using other types of COC before their switch to NuvaRing®. Any implication ... that NuvaRing® users are all new, naive users of hormonal contraception and all levonorgestrel users ... 4 years) we found significant differences in risk of VTE between users of NuvaRing® and COC with ...

  6. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Samuel Shapiro
    (Published 16 May 2012)

    could only have commenced in 2003, and for vaginal ring (NuvaRing) users in 2001 (the dates of ... contraceptives, including NuvaRing. In the past he has consulted with the manufacturer of EVRA. Venous thrombosis ...

  7. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Øjvind Lidegaard
    (Published 24 May 2012)

    thrombosis (9). According to the same study, NuvaRing® increases SHBG more than the majority of combined ... pills. The only other published study on the influence of NuvaRing® on the risk of venous thrombosis also ...

  8. Rapid Response

    Reduce VTE risk BEFORE hospital admission-but lets NOT talk about sex

    Lucinda Farmer
    (Published 30 January 2010)

    vaginal ring- Nuvaring(R). There are also oestrogen- containing contraceptive injectables available in ...

  9. Rapid Response

    Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

    Jane Skov
    (Published 19 May 2012)

    with manufacturers of hormonal contraceptives, including NuvaRing. Venous thrombosis in users of ...